|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-1-25
|
|
pubmed:abstractText |
Patients with a single episode of neurologic dysfunction and brain magnetic resonance imaging (MRI) scans suggestive of multiple sclerosis are at high risk for clinically definite multiple sclerosis, but the outcome for individual patients is unpredictable. An increased risk of progression to clinically definite multiple sclerosis in patients with serum antibodies against myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) has been reported.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta,
http://linkedlifedata.com/resource/pubmed/chemical/Myelin Basic Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Myelin Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Myelin-Associated Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/interferon beta-1b,
http://linkedlifedata.com/resource/pubmed/chemical/myelin oligodendrocyte glycoprotein
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:BarkhofFrederikF,
pubmed-author:DahmsSusanneS,
pubmed-author:DailyLL,
pubmed-author:EdanGillesG,
pubmed-author:FreedmanMark SMS,
pubmed-author:HartungHans-PeterHP,
pubmed-author:KapposLudwigL,
pubmed-author:KuhleJensJ,
pubmed-author:LindbergRaijaR,
pubmed-author:MehlingMatthiasM,
pubmed-author:MillerDavid HDH,
pubmed-author:MontalbanXavierX,
pubmed-author:PohlChristophC,
pubmed-author:PolmanChris HCH,
pubmed-author:SandbrinkRupertR
|
|
pubmed:copyrightInfo |
Copyright 2007 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
25
|
|
pubmed:volume |
356
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
371-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17251533-Adjuvants, Immunologic,
pubmed-meshheading:17251533-Adult,
pubmed-meshheading:17251533-Autoantibodies,
pubmed-meshheading:17251533-Brain,
pubmed-meshheading:17251533-Disease Progression,
pubmed-meshheading:17251533-Female,
pubmed-meshheading:17251533-Humans,
pubmed-meshheading:17251533-Immunoglobulin G,
pubmed-meshheading:17251533-Immunoglobulin M,
pubmed-meshheading:17251533-Interferon-beta,
pubmed-meshheading:17251533-Kaplan-Meier Estimate,
pubmed-meshheading:17251533-Magnetic Resonance Imaging,
pubmed-meshheading:17251533-Male,
pubmed-meshheading:17251533-Multiple Sclerosis,
pubmed-meshheading:17251533-Myelin Basic Proteins,
pubmed-meshheading:17251533-Myelin Proteins,
pubmed-meshheading:17251533-Myelin-Associated Glycoprotein,
pubmed-meshheading:17251533-Proportional Hazards Models
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Lack of association between antimyelin antibodies and progression to multiple sclerosis.
|
|
pubmed:affiliation |
Department of Research, University Hospital, Basel, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
